We are very pleased to announce that the Barcelonabeta Brain Research Center (BBRC) was the most successful trial delivery centre (TDC) in February with 14 newly screened participants in the EPAD Longitudinal Cohort Study (LCS). Congratulations to the entire team (pictured)!
The European Prevention of Alzheimer’s Dementia initiative (EPAD) recruited its first Spanish research participant in June 2016 via BBRC (Barcelona, Spain). It was the first site to open in Spain and the second in Europe and has currently recruited over 145 participants. It is the institute where the Pasqual Maragall Foundation conducts all the scientific activities and the research projects to fight Alzheimer’s disease. This center is a high-level technological infrastructure at the service of the clinical research for the prevention of Alzheimer’s. For more information visit https://www.barcelonabeta.org/
According to José Luis Molinuevo, EPAD co-leader and Scientific Director of the BBRC, “We are happy to be part of EPAD and contribute to its success. We are thankful to the commitment of the Alfa Study research participants, who are determined to contribute to change the history of the disease, and undoubtedly, to our EPAD TDC team, both key actors to our success”.
EPAD has opened several new sites in recent weeks. We currently have 12 sites enrolling and 510 research participants screened of which 465 are currently enrolled. We are delighted that the EPAD LCS study recruited 53 new participants in February, making it the most successful month to date. There is a major drive to open new sites in the coming days and weeks as well as enhance recruitment – Stay tuned.
Pictured: from the left: José Luis Molinuevo, Laia Tenas, Anna Soteras, Anna Brugulat, Carolina Herrero, Laura Hernández, Oriol Grau, Tania Menchón and Montserrat Vila